STATCenter·
Opinion: How a controversial rule could hurt the NIH’s ability to manage risk
The proposed rule could “weaken the NIH’s benign influence over research risks,” writes Doni Bloomfield.
Read at STAT →
Health · 1 sources covering this
Opinion: How a controversial rule could hurt the NIH’s ability to manage risk
The proposed rule could “weaken the NIH’s benign influence over research risks,” writes Doni Bloomfield.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/db47135b329f5545803d7786dff47e4e89ac7bb0" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Opinion: How a controversial rule could hurt the NIH’s ability to manage risk"></iframe>
